Top 10 Key Players companies in Cardiogenic shock by Highest Patent Value in the United States in 2021 – Discovery

Free Trial

The Cardiogenic shock top 10 is Discovery PatSnap’ annual ranking of the top 10 Highest Patent Value Cardiogenic shock Key Players in the United States. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2021, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.

1	PeriCor Therapeutics, Inc.	New York, United States	Medicine	Avg patent value: 2.15 M
2	Sunovion Pharmaceuticals, Inc.	Massachusetts, United States	Medicine,Pharmacy and Therapeutics,Inhalation, ...[+2]	Avg patent value: 530,000
3	ABIOMED, Inc.	Massachusetts, United States	Ventricular assist device,Medical equipment,Health care, ...[+2]	Avg patent value: 77,000
4	STARTUP MyoKardia, Inc.	California, United States	Medicine,Pharmacy and Therapeutics,Cardiovascular agent, ...[+2]	Avg patent value: 26,000
5	Procter & Gamble Co.	Ohio, United States	Toothpaste,Hair conditioner,SOAP, ...[+2]	Avg patent value: 0
6	Baxter International, Inc.	Illinois, United States	Clinical trial,Drug,Hemodialysis, ...[+2]	Avg patent value: 0
7	Eli Lilly & Co.	Indiana, United States	Medicine,Health care,Humalog Mix, ...[+2]	Avg patent value: 0
8	Medtronic, Inc.	Minnesota, United States	Medicine,Implantable cardiac pacemaker,Biomedical engineering, ...[+2]	Avg patent value: 0
9	Genentech, Inc.	California, United States	Biotechnology,Biology,Medicine, ...[+2]	Avg patent value: 0
10	STARTUP iMFLUX, Inc.	Ohio, United States	Software	Avg patent value: 0